1. Green Synthesis–Mediated Nanoparticles and Their Curative Character Against Post COVID-19 Skin Diseases

   • Nivedhitha Kabeerdass
   • Selvankumar Thangaswamy
   • Maghimaa Mathanmohun

   Naturopathy, Nanotechnology, Nutraceuticals, and Immunotherapy in Cancer Research (H Latha, Section Editors) 09 September 2022 Pages: 409 - 417

   

2. Lefamulin: a New Hope in the Field of Community-Acquired Bacterial Pneumonia

   • Shubham Adhikary
   • Meher Kaur Duggal
   • Ginpreet Kaur

   Clinical Pharmacology (L Brunetti, Section Editor) 06 July 2022 Pages: 418 - 426

   

3. Pathophysiological and Genetic Basis of Tenofovir-Induced Acute Renal Dysfunction: Strategies and Recent Developments for Better Clinical Outcomes

   • Ayush Sharma
   • Prakash Kumar
   • Sameer Dhingra

   Clinical Pharmacology (L Brunetti, Section Editor) 30 August 2022 Pages: 427 - 438

   

4. An Update on Advancements in Treatment Options for Managing Klebsiella pneumoniae Infections

   • Sunil Kumar
   • Razique Anwer
   • Manoj Singh

   Clinical Pharmacology (L Brunetti, Section Editor) 18 August 2022 Pages: 439 - 449

5. Nano-mediated Strategies for Metal Ion–Induced Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases

   • Karthick Harini
   • Koyeli Girigoswami
   • Agnishwar Girigoswami

   Nanodrugs (ATY Lau, Section Editor) 19 September 2022 Pages: 450 - 463

   

6. Correction to: Lefamulin: a New Hope in the Field of Community-Acquired Bacterial Pneumonia

   • Shubham Adhikary
   • Meher Kaur Duggal
   • Ginpreet Kaur

   Correction 02 November 2022 Pages: 464 - 466